Bionano Genomics to Present at the 2022 Maxim Virtual Growth Conference

Rhea-AI Summary

Bionano Genomics, known for its innovations in optical genome mapping, has announced that CEO Erik Holmlin will present at the 2022 Maxim Virtual Growth Conference. This event will take place on March 30, 2022, at 12:30 PM PT/3:30 PM ET. The conference can be accessed via the M-Vest platform, where participants can register and view the presentation. Bionano aims to transform genome analysis through its Saphyr® system and N_xClinical™ software, addressing critical questions in biology and medicine.

SAN DIEGO, March 23, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr^® system and provider of N_xClinical™ software, the leading solution for visualization, interpretation and reporting of genomic data, announced today that company management will present at the 2022 Maxim Virtual Growth Conference. Erik Holmlin, PhD, Bionano’s president and chief executive officer, will participate in a fireside chat on Wednesday, March 30th, 2022 at 12:30 pm PT/3:30 pm ET.  

The conference is hosted on the M-Vest site. Interested parties can register for the conference and view the fireside chat here: https://m-vest.com/events/2022-virtual-growth-conference.

About Bionano Genomics

Bionano Genomics is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software. The Company offers OGM solutions for applications across basic, translational and clinical research. Through its Lineagen business, the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. Through its BioDiscovery business, the Company also offers an industry-leading, platform-agnostic software solution, which integrates next-generation sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants and absence of heterozygosity across the genome in one consolidated view. For more information, visit bionanogenomics.com, lineagen.com or biodiscovery.com.

CONTACTS

Company Contact:
Erik Holmlin, CEO
Bionano Genomics, Inc.
+1 (858) 888-7610
eholmlin@bionanogenomics.com

Investor Relations:
Amy Conrad
Juniper Point
+1 (858) 366-3243
amy@juniper-point.com

FAQ

What is the date and time of Bionano Genomics' presentation at the Maxim Virtual Growth Conference?

Bionano Genomics' presentation will occur on March 30, 2022, at 12:30 PM PT/3:30 PM ET.

Who will represent Bionano Genomics at the 2022 Maxim Virtual Growth Conference?

Erik Holmlin, the CEO of Bionano Genomics, will represent the company.

How can I register for the 2022 Maxim Virtual Growth Conference featuring Bionano Genomics?

Interested parties can register for the conference and view the presentation at M-Vest's website.

What technology does Bionano Genomics focus on for genome analysis?

Bionano Genomics specializes in optical genome mapping and provides solutions for genomic data analysis.

What is the significance of the N_xClinical™ software provided by Bionano Genomics?

N_xClinical™ software is a leading solution for the visualization, interpretation, and reporting of genomic data.